Back to previous section

Director dealings: Smith & Nephew executives offload shares

Medical technology company Smith & Nephew disclosed two executive share sales on Wednesday, with its shares remaining flat after the announcement.

  • Smith & Nephew
  • 02 May 2024 08:40:18
Smith & Nephew

Source: Sharecast

Phil Cowdy, its chief corporate development and corporate affairs officer, sold 12,083 shares on 27 April for £12.83280 each, resulting in a total value of £155,058.72.

Following the sale, Cowdy still held 49,000.99390 ordinary shares, equivalent to 0.00558% of its issued share capital.

Bradley Cannon, the company’s president of global orthopaedics, meanwhile sold 9,500 shares on 2 May at a price of £12.926813 apiece, resulting in a total value of £122,804.72.

After the transaction, Cannon still held 117,819.37494 shares, or 0.01342% of the firm’s issued capital.

Both individuals still maintained a shareholding in line with the company's guidelines after the sale, the board confirmed.

Elsewhere, NB Private Equity Partners saw its shares rise after non-executive director Trudi Clark made a small share purchase.

Clark purchased 1,247 shares at a price of 15.9p, for a total value of £19,827.30.

At 1427 BST, shares in Smith & Nephew were flat at 1,298p, while those in NB Private Equity Partners were up 1.69% at 120p.

Reporting by Josh White for Sharecast.com.

FTSE 100 ( UKX )

Isin: N/A
Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 18.14 ( 0.22 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

Whether you're looking for a Share Dealing Account or Share Dealing ISA, we've got an account to suit your needs.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2024 Refinitiv, an LSEG business. All rights reserved.